Elizabeth L Yanik

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Infect Dis 57:756-64. 2013
  2. pmc Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Acquir Immune Defic Syndr 61:258-62. 2012
  3. pmc Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517, USA
    J Acquir Immune Defic Syndr 63:216-20. 2013
  4. doi request reprint Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence
    Elizabeth L Yanik
    aUniversity of North Carolina, Chapel Hill, North Carolina bNorthwestern University, Chicago, Illinois cUniversity of Washington, Seattle, Washington dUniversity of Alabama, Birmingham, Alabama eJohns Hopkins University, Baltimore, Maryland fUniversity of California, San Diego gUniversity of California, San Francisco, California, USA
    AIDS 28:979-87. 2014
  5. pmc Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era
    Satish Gopal
    Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Natl Cancer Inst 105:1221-9. 2013
  6. pmc Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011
    Elizabeth L Yanik
    Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, 715 Mary Ellen Jones Building, Chapel Hill, NC, USA
    Infect Agent Cancer 8:18. 2013
  7. pmc HIV and proteinuria in an injection drug user population
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Clin J Am Soc Nephrol 5:1836-43. 2010

Detail Information

Publications7

  1. pmc Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Infect Dis 57:756-64. 2013
    ..Cancer is an important cause of morbidity and mortality in individuals infected with human immunodeficiency virus (HIV), but patterns of cancer incidence after combination antiretroviral therapy (ART) initiation remain poorly characterized...
  2. pmc Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Acquir Immune Defic Syndr 61:258-62. 2012
    ..AHI was associated with 1.9 times the prevalence of TDR (95% confidence intervals: 1.0 to 3.6) in multivariable analysis. AHI patients may represent a vanguard group that portends increasing TDR in the future...
  3. pmc Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517, USA
    J Acquir Immune Defic Syndr 63:216-20. 2013
    ..However, only 40% received 1 or more lipid tests. Monitoring was more frequent in specific subgroups, likely reflecting better clinic attendance or clinician perception of higher susceptibility to toxicities...
  4. doi request reprint Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence
    Elizabeth L Yanik
    aUniversity of North Carolina, Chapel Hill, North Carolina bNorthwestern University, Chicago, Illinois cUniversity of Washington, Seattle, Washington dUniversity of Alabama, Birmingham, Alabama eJohns Hopkins University, Baltimore, Maryland fUniversity of California, San Diego gUniversity of California, San Francisco, California, USA
    AIDS 28:979-87. 2014
    ..To estimate the association between immunologic response to antiretroviral therapy (ART) and non-AIDS defining cancer (NADC) incidence in HIV-infected patients...
  5. pmc Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era
    Satish Gopal
    Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Natl Cancer Inst 105:1221-9. 2013
    ..Lymphoma is the leading cause of cancer-related death among HIV-infected patients in the antiretroviral therapy (ART) era...
  6. pmc Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011
    Elizabeth L Yanik
    Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, 715 Mary Ellen Jones Building, Chapel Hill, NC, USA
    Infect Agent Cancer 8:18. 2013
    ..We assessed changes in the distribution of cancer types and incidence trends among HIV-infected patients in North Carolina up until 2011...
  7. pmc HIV and proteinuria in an injection drug user population
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Clin J Am Soc Nephrol 5:1836-43. 2010
    ..Proteinuria is a major determinant of chronic kidney disease. We aimed to characterize the prevalence and correlates of proteinuria in a cohort of HIV-infected and uninfected injection drug users...